Revolution Medicines, Inc.: cashflow_financing

Value{"amount": 250069000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"}
Period2022-01-01 – 2022-09-30
Statuscurrent
EntityRevolution Medicines, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0000950170-22-022590 · Open the official SEC filing →
Retrieved: 2026-08-19T16:44:57.191003+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001628171/cashflow-financing/2022-09-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/cf7bc4d1-e1b0-4a85-a1c3-5e0ca4e0cefc

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies